ATHENAS - Retrospective Study of Compliance in Chronic Hepatitis C With Pegylated Interferon Alfa-2b/Ribavirin in Brazil (P05632)

NCT00856024 · clinicaltrials.gov ↗

TERMINATED

Status

902

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

BIOLOGICAL: Peginterferon alfa-2b
DRUG: Ribavirin

Sponsor

Merck Sharp & Dohme LLC